Jason Hoitt

Jason Hoitt has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Stoke Therapeutics, Inc. and Provention Bio, Inc. We count 3 filings; the first trade dates from 10 February 2023 and the latest from 17 March 2026.

Sales make up the whole of the open-market record (2 sales, €71k). Other entries cover 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 19 March 2026, the filings show an open-market sale worth €29k in Stoke Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.